Outcome prediction in disorders of consciousness: the role of coma recovery scale revised.


Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
18 Apr 2019
Historique:
received: 12 11 2018
accepted: 31 03 2019
entrez: 20 4 2019
pubmed: 20 4 2019
medline: 14 6 2019
Statut: epublish

Résumé

To evaluate the utility of the revised coma remission scale (CRS-r), together with other clinical variables, in predicting emergence from disorders of consciousness (DoC) during intensive rehabilitation care. Data were retrospectively extracted from the medical records of patients enrolled in a specialized intensive rehabilitation unit. 123 patients in a vegetative state (VS) and 57 in a minimally conscious state (MCS) were included and followed for a period of 8 weeks. Demographical and clinical factors were used as outcome measures. Univariate and multivariate Cox regression models were employed for examining potential predictors for clinical outcome along the time. VS and MCS groups were matched for demographical and clinical variables (i.e., age, aetiology, tracheostomy and route of feeding). Within 2 months after admission in intensive neurorehabilitation unit, 3.9% were dead, 35.5% had a full recovery of consciousness and 66.7% remained in VS or MCS. Multivariate analysis demonstrated that the best predictor of functional improvement was the CRS-r scores. In particular, patients with values greater than 12 at admission were those with a favourable likelihood of emergence from DoC. Our study highlights the role of the CRS-r scores for predicting a short-term favorable outcome.

Sections du résumé

BACKGROUND BACKGROUND
To evaluate the utility of the revised coma remission scale (CRS-r), together with other clinical variables, in predicting emergence from disorders of consciousness (DoC) during intensive rehabilitation care.
METHODS METHODS
Data were retrospectively extracted from the medical records of patients enrolled in a specialized intensive rehabilitation unit. 123 patients in a vegetative state (VS) and 57 in a minimally conscious state (MCS) were included and followed for a period of 8 weeks. Demographical and clinical factors were used as outcome measures. Univariate and multivariate Cox regression models were employed for examining potential predictors for clinical outcome along the time.
RESULTS RESULTS
VS and MCS groups were matched for demographical and clinical variables (i.e., age, aetiology, tracheostomy and route of feeding). Within 2 months after admission in intensive neurorehabilitation unit, 3.9% were dead, 35.5% had a full recovery of consciousness and 66.7% remained in VS or MCS. Multivariate analysis demonstrated that the best predictor of functional improvement was the CRS-r scores. In particular, patients with values greater than 12 at admission were those with a favourable likelihood of emergence from DoC.
CONCLUSIONS CONCLUSIONS
Our study highlights the role of the CRS-r scores for predicting a short-term favorable outcome.

Identifiants

pubmed: 30999877
doi: 10.1186/s12883-019-1293-7
pii: 10.1186/s12883-019-1293-7
pmc: PMC6472098
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

68

Références

Neurology. 2002 Feb 12;58(3):349-53
pubmed: 11839831
Online J Knowl Synth Nurs. 1997 Feb 26;4:1
pubmed: 12876658
Arch Phys Med Rehabil. 2004 Dec;85(12):2020-9
pubmed: 15605342
Arch Phys Med Rehabil. 2005 Apr;86(4):746-54
pubmed: 15827927
Brain Inj. 2005 Jun;19(6):425-36
pubmed: 16101265
Neuropsychol Rehabil. 2005 Jul-Sep;15(3-4):166-74
pubmed: 16350959
J Am Geriatr Soc. 2006 Oct;54(10):1590-5
pubmed: 17038079
Arch Phys Med Rehabil. 2008 May;89(5):896-903
pubmed: 18452739
J Neurotrauma. 2008 Sep 4;:null
pubmed: 18771395
Arch Phys Med Rehabil. 1991 Oct;72(11):897-901
pubmed: 1929808
Prog Brain Res. 2009;177:63-72
pubmed: 19818895
Prog Brain Res. 2009;177:73-88
pubmed: 19818896
Brain Inj. 2009 Nov;23(12):973-80
pubmed: 19831494
BMC Med. 2010 Nov 01;8:68
pubmed: 21040571
Nephrol Dial Transplant. 2011 Jan;26(1):56-61
pubmed: 21059831
J Neurotrauma. 2012 Jan 1;29(1):59-65
pubmed: 21663544
J Neurol. 2011 Jul;258(7):1373-84
pubmed: 21674197
Neurology. 2013 Jan 29;80(5):464-70
pubmed: 23303855
Arch Phys Med Rehabil. 2013 Oct;94(10):1908-23
pubmed: 23732166
Arch Phys Med Rehabil. 2013 Oct;94(10):1851-4
pubmed: 23856152
Clin Neurol Neurosurg. 2013 Oct;115(10):2136-41
pubmed: 23993657
BMC Neurol. 2013 Nov 06;13:164
pubmed: 24195685
Nat Rev Neurol. 2014 Feb;10(2):99-114
pubmed: 24468878
Eur J Phys Rehabil Med. 2015 Oct;51(5):627-34
pubmed: 24603937
Ann Clin Transl Neurol. 2014 Jun;1(6):401-8
pubmed: 25356410
J Neurotrauma. 2016 Feb 15;33(4):423-4
pubmed: 26203818
Ann Neurol. 2015 Oct;78(4):594-605
pubmed: 26290126
Nephrol Dial Transplant. 2016 Feb;31(2):317-24
pubmed: 26320038
Arch Phys Med Rehabil. 2016 Mar;97(3):490-492.e1
pubmed: 26342571
J Neurol. 2016 May;263(5):937-953
pubmed: 26984609
Arch Phys Med Rehabil. 2018 Dec;99(12):2523-2531.e3
pubmed: 29807003
N Engl J Med. 1994 May 26;330(21):1499-508
pubmed: 7818633
Arch Phys Med Rehabil. 1995 Feb;76(2):205-9
pubmed: 7848080
Arch Phys Med Rehabil. 1997 Aug;78(8 Suppl 4):S12-6
pubmed: 9270483

Auteurs

Lucia Francesca Lucca (LF)

S. Anna Institute and Research in Advanced Neurorehabilitation (RAN), 88900, Crotone, Italy. l.lucca@istitutosantanna.it.

Danilo Lofaro (D)

Dipartimento di Ingegneria Meccanica, Energetica e Gestionale - DIMEG, UNICAL, Arcavata di Rende (CS), Rende, Italy.
Kidney and Transplantation Research Center, Annunziata Hospital, Cosenza, Italy.

Loris Pignolo (L)

S. Anna Institute and Research in Advanced Neurorehabilitation (RAN), 88900, Crotone, Italy.

Elio Leto (E)

S. Anna Institute and Research in Advanced Neurorehabilitation (RAN), 88900, Crotone, Italy.

Maria Ursino (M)

S. Anna Institute and Research in Advanced Neurorehabilitation (RAN), 88900, Crotone, Italy.

Maria Daniela Cortese (MD)

S. Anna Institute and Research in Advanced Neurorehabilitation (RAN), 88900, Crotone, Italy.

Domenico Conforti (D)

Kidney and Transplantation Research Center, Annunziata Hospital, Cosenza, Italy.

Paolo Tonin (P)

S. Anna Institute and Research in Advanced Neurorehabilitation (RAN), 88900, Crotone, Italy.

Antonio Cerasa (A)

S. Anna Institute and Research in Advanced Neurorehabilitation (RAN), 88900, Crotone, Italy. antonio.cerasa76@gmail.com.
Neuroimaging Unit, IBFM-CNR, 88100, Catanzaro, Italy. antonio.cerasa76@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH